influenza%20(pediatric)
INFLUENZA (PEDIATRIC)
Influenza may present as a mild respiratory illness similar to the common cold or it may present without characteristic signs and symptoms.
The main type of influenza virus are types A, B & C virus. Types A&B are the main causes of influenza outbreaks.
Patient may appear flushed and have pain on eye movement. Non-exudative pharyngitis, scattered rales or rhonchi may be present.

Antiviral Agents

  • Option for the control of influenza, but should not be used as a substitute to influenza vaccination

Prophylaxis

  • Antiviral agents may be used to prevent spread of influenza during an influenza outbreak in an institutionalized setting
  • May be used in persons who cannot be vaccinated due to contraindications to vaccine
    • Do not start until influenza epidemic has begun & stop only when epidemic is over
  • May be used in persons at high-risk for complications who have been vaccinated after an outbreak of influenza has begun
    • Give for 2 weeks starting from day of vaccination to give sufficient time for immunity to develop

Treatment

  • When used within 48 hours of symptom onset, antiviral agents may reduce the duration of symptoms
    • Should not be used if there is uncertainty about diagnosis or if bacterial infection cannot be ruled out
    • Administration of antiviral treatment may be considered in very ill or high-risk suspected influenza patients even without confirmed tests if:
      • Currently admitted
      • Categorized as severe, complicated, or with progressive disease
      • At high risk for complications (ie immunocompromised, <2 years of age, with comorbidities)
      • Receiving long-term Aspirin treatment
  • None of the following agents have been shown to be effective in preventing serious influenza-related complications
  • Data is limited concerning effectiveness of the antiviral agents for the treatment of patients at high-risk of serious complications of influenza

Adamantanes

  • Eg Amantadine, Rimantadine
  • Consider local resistance data when prescribing adamantanes for patients with influenza
  • Chemoprophylaxis & treatment against circulating influenza A virus strains using adamantanes are not recommended because of increasing reports of drug resistance
  • Possesses little or no activity against influenza type B virus

Neuraminidase Inhibitors

  • Eg Oseltamivir, Peramivir, Zanamivir
  • Oral Oseltamivir & inhaled Zanamivir are used for treatment & prophylaxis of infection with influenza A or B viruses
    • Oral Oseltamivir is the antiviral drug of choice for the management of influenza infections
    • Inhaled Zanamivir may be used as an alternative treatment for those without any chronic lung disease
  • Recently approved intravenous Peramivir can be used for treatment of acute uncomplicated influenza in nonhospitalized children ≥2 years of age
  • Studies are still being conducted on the use of intravenous Zanamivir for seasonal influenza but may be considered in newly emergent Oseltamivir- or Peramivir-resistant virus
  • Effects:
    • As treatment: Can reduce duration of uncomplicated influenza A & B illness by approximately 1 day compared with placebo when used within 2 days of illness onset
    • Both drugs are effective, 82% (Oseltamivir) or 84% (Zanamivir), in preventing febrile, laboratory-confirmed influenza illness in otherwise healthy individuals
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Saras Ramiya, 3 days ago
US researchers show split liver transplantation and living donor liver transplantation (LDLT) may be superior to whole liver transplantation in improving outcomes in paediatric patients.
27 Nov 2017
Chronic hepatitis B virus (HBV) infection is a global problem. Chronic HBV infection is probably the most common maternal infection encountered in Hong Kong, China, and Southeast Asia. In Hong Kong, which is one of the endemic areas, immunisation against HBV was first provided in 1983 to infants born to mothers who were screened positive for hepatitis B surface antigen (HBsAg). Immunisation became widespread since November 1988, but HBsAg-positive mothers are still encountered frequently.1
Sudeta D Connolly, Sonali Nanayakkara, 01 Aug 2011

Anxiety disorders are one of the most common psychiatric disorders in children and adolescents, but they often go undetected or untreated. Identification and effective treatment of childhood anxiety disorders can decrease the negative impact of these disorders on academic and social functioning in youth and their persistence into adulthood. Because of the national shortage of child and adolescent psychiatrists in the US, paediatricians are increasingly called on to be front-line partners with child mental health professionals to coordinate care—with screening and early identification as well as with multimodal treatment of childhood anxiety disorders.

2 days ago
Dr Michael Lim, consultant of the Division of Paediatric Pulmonary and Sleep in National University Hospital, Singapore, shares his insights with Pearl Toh on diagnosing and managing paediatric asthma in the primary care setting.